Document and discard a hemolyzed specimen to preserve result integrity in chemistry labs

When a sample shows hemolysis before analysis, the primary action is to document the issue and discard the specimen. This prevents misleading results caused by cellular contents in serum or plasma and keeps clinical decisions reliable while guiding proper specimen handling and quality control.

Hemolyzed samples in the chemistry lab: what to do and why it matters

If you’ve spent any time in a clinical chemistry lab, you know hemolysis is more than just a pink tint in a specimen. It’s a red flag that can throw off the whole picture you’re trying to paint from a patient’s blood work. Hemolysis happens when red blood cells rupture, releasing their contents into the plasma or serum. That leakage can skew many analyte measurements and cloud the clinical story behind the numbers. So, what should you do the moment you spot a hemolyzed sample before you run any tests? The answer is simple, disciplined, and crucial for patient safety: document it and discard the sample.

Let’s unpack why this is the right move and what it means in everyday lab practice.

The why behind the action

Think of a lab result as a snapshot of a patient’s physiology at a precise moment. When hemolysis occurs, the snapshot becomes distorted. Potassium, for instance, is largely inside red blood cells. When those cells break, potassium leaks out, and the measured level may appear higher than it truly is. Lactate dehydrogenase, another enzyme abundant in red cells, can surge in a hemolyzed specimen. But the effects aren’t limited to a couple of tests. Numerous chemistry panels can be affected by even mild hemolysis, and the pattern of interference can vary by analyte and by the methodology used by the analyzer. The bottom line: results from a hemolyzed sample can mislead clinicians, potentially impacting patient care.

Documenting the issue is about transparency and traceability. It creates a clear record that hypertens a lab’s quality control narrative. If a clinician later questions a result, the note about hemolysis is a key data point. It’s not simply “we had a bad sample”; it’s a reminder that the sample’s pre-analytic phase introduced a factor that could bias results. Documentation also supports ongoing QA processes, helping laboratories track how often hemolysis occurs and identify patterns that might point to collection or handling issues.

Discarding is about safeguarding accuracy

Discarding a hemolyzed sample isn’t about wastefulness; it’s about preserving the integrity of the testing process. The chemistry analyzer can carry on with a clean, non-hemolyzed specimen, which yields more reliable data. Some laboratories will proceed with specific tests if a hematology flag confirms the degree of hemolysis is mild and known interferences can be accounted for, but that’s a decision governed by established protocols and the particular tests involved. In the general case, when a sample is hemolyzed, it’s safer to reject it and request a redraw.

Here’s a practical way to frame the moment of decision:

• Recognize and confirm: A hemolyzed appearance should trigger an alert in the LIS (laboratory information system) or be spotted during the pre-analytical check. It’s not something you ignore or push past just to keep the workflow moving.

• Document clearly: Record the degree of hemolysis (if a semi-quantitative scale is available) and note the affected tests or panel. Include any visual cues and, if appropriate, the suspected cause (e.g., difficult draw, prolonged tourniquet time). This note travels with the specimen’s record and informs downstream users.

• Communicate promptly: Notify the ordering clinician and the patient-care team about the issue and the plan. Communication is not a formality; it’s a safeguard against misinterpretation and mismanagement of care.

• Discard and redraw: Place the hemolyzed sample in the proper discard stream and request a new draw. Where feasible, review the collection technique to prevent recurrence—lighter tourniquet pressure, proper needle size, and thorough mixing after collection are simple steps with big payoffs.

• Reassess the plan: When the new sample arrives, recheck the patient’s clinical context. If a repeat draw isn’t possible promptly, some labs may offer alternative testing strategies with caveats, but those are decision points for the clinical lab team and the provider.

Quality control and pre-analytic vigilance

Hemolysis isn’t a one-off nuisance; it’s a proxy for how a specimen has traveled from patient to analyzer. Pre-analytic quality control focuses on everything before the instrument starts measuring. The journey includes the vein, the needle, the syringe or collection tube, the transportation container, the time elapsed, and the handling steps in between. Each link in that chain is a potential source of hemolysis.

A few practical tips, drawn from everyday lab life, help keep hemolysis at bay:

• Use proper collection techniques: Have patients relaxed, stationed at a comfortable height, and avoid excessive probing for a vein. Gentle but secure needle insertion, appropriate syringe size, and correct tube filling can reduce mechanical trauma to cells.

• Watch tourniquet timing: A tourniquet left on too long can cause hemoconcentration and potentially contribute to hemolysis during the draw. Remove the tourniquet as soon as blood begins to flow.

• Mix gently, not vigorously: Some clinicians worry about clots if they don’t mix. The right move is gentle inversion—enough to distribute additives without shear forces that could damage cells.

• Check transport and handling: Vibration, cold chain breaks, or rough handling during transport can contribute to cell rupture. Stable, consistent handling preserves sample integrity.

• Train and audit: Regular feedback loops help staff recognize hemolysis early, and audits can identify common contributing factors. Small adjustments can yield noticeable improvements over time.

What if hemolysis is mild? alternatives and caveats

There are scenarios where a sample shows only a trace of hemolysis, and the lab team may decide to proceed with certain tests while noting the potential interference. This is a nuanced call, not a blanket rule. The decision hinges on the specific tests, the degree of hemolysis, and the clinical context. Some analytes are more forgiving, while others are highly sensitive to red cell rupture. In any case, the lab will document the interference and share guidance with the healthcare team, ensuring that interpretation comes with a caveat rather than a confident misread.

The human side of the science

Behind every result is a patient—someone who relies on precise information to guide care. That human element shapes how labs approach hemolyzed samples. It’s about responsibility, not just compliance or speed. The moment you notice hemolysis, you’re stepping into a responsibility corridor: acknowledge, document, protect the patient by discarding the compromised specimen, and ensure a clean redraw.

As a lab worker, you also become a translator between raw measurements and meaningful conclusions. Numbers don’t speak for themselves; clinicians rely on the integrity of the specimen and the clarity of the report. When you document correctly and discard the hemolyzed sample, you’re not just following a rule—you’re preserving the trust that makes medical decisions safe and effective.

A few real-world reflections to tie it together

• The best-laid plan meets reality in the pre-analytic phase. Even in busy hospital settings, small improvements—like reinforcing best practices for phlebotomy—can dramatically reduce the frequency of hemolyzed samples.

• Communication isn’t an afterthought. A quick note to the care team about a compromised specimen can prevent downstream misinterpretations and unnecessary follow-ups.

• The lab culture matters. When teams treat every specimen with careful respect for its potential to tell a clinical story, the whole institution benefits. Accuracy isn’t a luxury; it’s a baseline expectation.

A brief tour of the broader implications

Hemolysis flags the fragility of the process that turns a patient’s blood into actionable data. It reminds us that results aren’t just numbers in a computer; they’re outcomes in real lives. The discipline to document and discard isn’t a reaction to a mistake—it’s a practice that honors the patient and reinforces the clinician’s confidence in the data.

If you’re new to the field or stepping into a chemistry lab for the first time, treat hemolysis as a signal. It says: “Pause, verify, and protect.” It’s not about fear of error; it’s about safeguarding accuracy and fostering a culture where quality isn’t optional, it’s expected.

A closing thought—the everyday worth of good habits

You don’t need dramatic changes to make a difference. A few mindful habits—check for hemolysis early, document clearly, notify promptly, and redraw when needed—can accumulate into a robust standard of care. It’s a small set of actions, but in a clinical setting, they carry enormous weight. And that weight isn’t a burden; it’s a badge of diligence, a quiet promise that the numbers reflecting a patient’s condition are as trustworthy as humanly possible.

So next time a sample looks a bit too pink to be comfortable, you’ll know what to do. Document it, discard it, and keep moving forward with a fresh specimen ready to tell the true story. The goal isn’t perfection in every draw—it's consistent reliability in the data that healthcare teams can rely on, day after day. That reliability is what keeps patient care precise, informed, and safe. And that, in the end, makes all the difference.